ADAI News & Events
May 26, 2021
New Study: Buprenorphine for Opioid Use Disorder Underused in Washington State
Opioid use disorder (OUD) is a major concern in the United States. Treatment medications like methadone and buprenorphine have been found to be effective at improving functioning and reducing deaths, with longer treatment periods leading to better outcomes for health issues, quality of life, employment, and more. Because people do better when they stay on…
May 10, 2021
In the News: Overdose Deaths in WA Up 30% in 2020
According to preliminary data from the state Department of Health, as reported by the Seattle Times, fatal drug overdoses in Washington State increased by more than 30% in 2020 compared to the previous year — an increase more than twice as large as any other year in the past decade. Deadly opioid overdoses increased even…
May 4, 2021
Learn About Opioid and Stimulant Use in Two New ADAI Briefs
ADAI recently published two new research briefs, both about opioid and stimulant use, and both written by ADAI researchers K. Michelle Peavy, PhD, Caleb Banta-Green, PhD, MPH, MSW, and Mandy Owens, PhD. Opioids and Stimulants: What Are They and How Are People Using Them? This 9-page report: examines the combined opioid/stimulant picture; reviews opioid and…
April 8, 2021
ADAI Stands with Our Asian and Asian American Friends, Family, Colleagues, and Community Members
We are deeply disturbed and saddened by the rise in anti-Asian and anti-Asian American hate crimes throughout the country. The recent attack on a Japanese language teacher in the International District and vandalizing of two Asian American churches in North Seattle show that the Seattle area is no exception to violence against these communities. Particularly…
March 30, 2021
The Potential Role of “Budtenders” in Responsible Use Education with Adult Cannabis Consumers
Cannabis legalization in Washington State dramatically increased the availability, use, and potency of cannabis products for adults 21 and older. Public health education promoting safe use for adult consumers has lagged behind these trends. Cannabis retail workers (“budtenders”) help customers select products and are knowledgeable about the store’s inventory. Those helping customers with medicinal cannabis…
March 29, 2021
New Webinars Page on StopOverdose.org
StopOverdose.org, a project from the ADAI Center for Drug Safety and Education Services Education unit, recently added a new page to host its webinar series. Webinar topics have included: Criminal legal fines and their impact on opportunity and inequality, with Dr. Alexes Harris, March 2021 Hepatitis C Treatment in WA: Lummi Tribal Health Center &…
March 23, 2021
Dr. Banta-Green on Northwest Now: “If you build the right care, people will show up.”
ADAI Principal Research Scientist Caleb Banta-Green, PhD appeared on Northwest Now (KBTC/PBS) this week to talk about COVID’s impacts on substance use and overdose; the importance of harm reduction approaches targeted toward those with severe patterns of use; and the Blake decision overturning the state’s criminal drug possession laws. In terms of the Blake decision,…
Position Available: Addiction Medicine Clinical Researcher at Hennepin Healthcare (Univ. of Minnesota)
The Addiction Medicine Division at Hennepin Healthcare seeks a full-time Clinical Researcher (MD or other doctoral level clinician) whose addiction-related research interests include health disparities and safety-net populations, integrated models of addiction care in general medical settings, implementation science, health services research, or pragmatic clinical trials. Position will be eligible for Assistant/Associate Professor appointment at the University of Minnesota. Position…
March 19, 2021
New from the Northwest ATTC: Clinical EBP Demonstration Video Series for Telehealth
The Northwest ATTC’s new Clinical EBP Demonstration Video Series intends to demonstrate how a diverse set of clinical practitioners make use of evidenced based practices (EBP) in a telehealth environment. The impetus for these videos came from a provider survey and our organization partners who identified “Clinical Demonstration” as a needed product, especially with the recent…
March 16, 2021
Webinar: Daily Cannabis Use During Pregnancy and Postpartum: Patient, Provider, & Budtender Perspectives (March 31, 12pm)
Join the Northwest ATTC on March 31 (12-1pm PT) for the third installation in its Pregnant/Parenting People and Substance Use webinar series: Daily Cannabis Use During Pregnancy and Postpartum: Patient, Provider, & Budtender Perspectives, presented by Dr. Celestina Barbosa-Leiker. This presentation will cover a series of research studies focused on perceptions of risk of cannabis…
Previous page Next page
